Found 36 matching trials
TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL) PHASE1 PBLTT52CAR19 modified T cells are allogenic engineered human T cells (defin...
Show More Location
Great Ormond Street Hospital
Learn More & Join Trial
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management N/A An increasing number of cancer patients are eligible to receive immunothera...
Show More Location
Medical Clinical Research Platform, Cancer Institute of the Hospices Civils de Lyon
Learn More & Join Trial
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin PHASE1 The purpose of this Phase I study is to test the safety of different doses ...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
Learn More & Join Trial
Axi-cel in CNS Lymphoma PHASE1 This research is being done to test the safety and effectiveness of axicabt...
Show More Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Learn More & Join Trial
B7-H3.CD28Z.CART in Solid Tumors PHASE1 The goal of this research study is to test if a new cell therapy (B7-H3.CD2...
Show More Location
Dana Farber Cancer Institite
Learn More & Join Trial
Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma PHASE2 This phase II study will evaluate the efficacy, safety and tolerability of ...
Show More Location
Medizinische Klinik A Hämatologie, Hämostaseologie, Onkologie und Pneumologie Universitätsklinikum Münster
Learn More & Join Trial
Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy EARLY_PHASE1 In this clinical study, participants with advanced renal cell carcinoma wil...
Show More Location
Multiple Locations
Learn More & Join Trial
VitalTraq for the Detection of CRS NA The purpose of this study is to evaluate two vital sign monitoring devices,...
Show More Location
Duke Blood Cancer Center
Learn More & Join Trial
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy NA The proposed multimodal telerehabilitation model allows a rehabilitation th...
Show More Location
Huntsman Cancer Institute at University of Utah
Learn More & Join Trial
NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma PHASE2 This study will evaluate the safety and efficacy of NKTR-255 following CD19...
Show More Location
University of California San Diego
Learn More & Join Trial